Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer

Pancreatic cancer patients have a high risk of venous thromboembolism (VTE). Plasminogen activator inhibitor 1 (PAI-1) inhibits plasminogen activators and increases the risk of thrombosis. PAI-1 is expressed by pancreatic tumors and human pancreatic cell lines. However, to date, there are no studies...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Blood Adv
Asıl Yazarlar: Hisada, Yohei, Garratt, Kenison B., Maqsood, Anaum, Grover, Steven P., Kawano, Tomohiro, Cooley, Brian C., Erlich, Jonathan, Moik, Florian, Flick, Matthew J., Pabinger, Ingrid, Mackman, Nigel, Ay, Cihan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2021
Konular:
Thrombosis and Hemostasis
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839372/
https://ncbi.nlm.nih.gov/pubmed/33496742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003149
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller